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CENTRAL RETINAL VEIN OCCLUSION TREATED WITH
ANTICOAGULANT AND STEROID THERAPY:
CASE REPORT AND DISCUSSION
DAVID BARSKY, M.D.*

Central retinal vein occlusion was noted by clinicians in the very early days of
ophthalmoscopy.

Michel', in 1878, was the first to publish the classical description;

he concluded that most cases were due to thrombosis. Vehhoeff^ (1906) contended that
the occlusion was due to an endothelial proliferation. Since then there have been
many controversies regarding the etiology of the occlusion. The general prognosis in
untreated cases is poor and visual acuity usually decreases; 10% to 20% go on to
hemorrhagic glaucoma and eventually enucleation.

In keeping with the thrombosis

theory, anticoagulant therapy has recently become a popular mode of management.
However, the statistics are scanty and difficult to evaluate because many of the treated
cases are of a selected group, and there is great variability with spontaneous recovery
in many cases. Duff, Falls and Linman,' in 1951, reported that of a control (untreated)
group of 70 patients with complete central vein occlusion, only 15% recovered above
the level recorded at the initial visual acuity examination. Whereas, in 22 "selected
cases" on Bishydroxycoumarin, 30% showed improvement of 0.1 or better over their
initial visual acuity examination. The anticoagulant therapy was begun from 1 day to
5 weeks after the onset of symptoms and maintained for an average of 3 months. The
prothrombin time was kept at 20% to 30% of normal. Gasparri,* in Italy (1952),
reported "good" results in 64% of 25 cases treated with Tromexan anticoagulant. Klien^
advocates a prolonged maintenance dose of anticoagulant in the preventive management
of venous occlusion, by keeping the prothrombin time at about 50% of normal.
CASE REPORT
This 36 year old female was first seen at H. F. H. on March 24, 1955 with
the complaint of blurring of the vision of her left eye for four days. The blurring had
come on suddenly with no pain or redness. She had been seen three days previously
by an ophthalmologist, who had diagnosed occlusion of the central retinal vein and
referred her to the H . F. H . for treatment. She believed the blurred vision had come
on almost instantaneously with no warning symptoms. The onset was not related to
any trauma or associated general iflness. Her corrected vision previously had been good
in both eyes.
Past history revealed the patient had had nephritis at the age of 4 years, and
scarlet fever at the age of 11 years. Foflowing the latter, she had had attacks of
arthritis and nephritis for a 4 month period, but no apparent sequelae after that time.
Between the ages of 26 and 30 she had had 6 miscarriages, but with hormone therapy
she had delivered 2 living children. Family history revealed one sister had healed
tuberculosis.
* Resident Physician, Department of Ophthalmology
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Examination on 3-24-55 revealed the following:
Visual acuity:

sc RE
cPC RE

Manifest:

20/70, L E : 20/80
— 1.50 sph. + .50 cyl. x 150 =

20/20

RE

— 1.00 sph.

=

20/40

RE

— 2.00 sph. + .25 cyl. x 130 =

20/20

LE

— 1.50 sph. + .25 cyl. x

20/30

90 =

On external examination the position, lids, EOM, tactile tension, lacrimal apparatus,
cornea, conjunctiva, sclera, anterior chambers and irides were normal. The pupfls were
central, equal and reactive to light and accommodation.
On slit lamp examination, both anterior segments were normal; and with the
Hruby lens the right vitreous was normal, but some red cefls could be seen in the
posterior part of the left vitreous. Intraocular tension measured RE 17, LE 17 (Schiotz).
Muscle examination revealed an NPC of 60 mms., and for distance vision and near
vision there was vertical and horizontal orthophoria. Ductions were full and versions
were normal.
Ophthalmoscopic examination showed the following: RE; Media clear. Disc
normal in size, shape and color, with physiological cupping of normal depth. The retinal
vessels were normal. On the superior nasal border of the disc there was a juxtapapfllary
area of chorioretinal atrophy approximately 2 disc diameters in size, with a margin
of heavy pigmentation. The peripheral retina was normal. LE; Media clear. Disc
margins blurred and difficult to make out. Retinal veins greatly dilated and tortuous
everywhere. Throughout the retina, both peripherally and centrally and including all
four quadrants, there was an extensive mottling of small scattered hemorrhages, with
sflght edema but very little exudate. In the macular area there was some slight edema
with many small hemorrhages. In the inferotemporal quadrant there was an area of
chorioretinal atrophy approximately 2 disc diameters in size, with a margin of pigmentation. In the center of this atrophic scar a retinal vein anastomosed with the choroidal
circulation.
Initial impression was: 1) Occlusion of central retinal vein, left eye, 2) Old
healed chorioretinitis, OU, and 3) Compound myopic astigmatism, OU.
The patient was admitted for immediate therapy with anticoagulants. In an attempt
to minimize the reaction in the macular area, ACTH was started ten days after
admission, being administered in the form of Armour's gel in a dosage of 30 u. twice
daily. Vision in the left eye promptly improved from 20/40 to 20/25—. It was quite
difficult to control the exact dosage of hedulin whfle the patient was on ACTH therapy
and there was a great deal of fluctuation in her prothrombin time. The ACTH was
discontinued after one week of therapy; however, on cessation of the ACTH vision in
the left eye fell again to 20/70. The reaction in the left eye appeared to have settled
and two days later the patient was discharged in the care of her local ophthalmologist,
on a maintenance dose of hedulin 100 mgs. daily.
Eight days later he advised her to return to the Henry Ford Hospital for further
therapy because examination by him at that time suggeted there might be an extension
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of the thrombotic process. Consequently the patient was readmitted on 4-22-55 and on
this admission was found to have corrected visual acuities of RE 20/20 and L E 20/70.
Tension was normal, OU. Ophthalmoscopic examination of the left eye showed no
change except that there seemed to be a few more hemorrhages than had been noted
at the time of her discharge. The patient was again placed on A C T H therapy 40 u.
b.i.d. with a low salt diet and a supplement of 1 gm. K C l daily. As the prothrombin
time on the day of admission was found to be prolonged beyond the upper limit of 2
minutes, vitamin K i oxide was given intravenously. By the third day the prothrombin
time had dropped back to within normal limits and hedulin was resumed. Throughout
this hospital stay, too, anticoagulant therapy was quite irregular in its effectiveness and
the prothrombin time ranged from 80% to 20% of normal, even though the dafly dose
of hedulin was correlated with the prothrombin time. It was felt at the time that ACTH
might well have been the contributing factor to this irregularity. The A C T H was kept up
for one week and then the patient was transferred to a regime of prednisolone
5 mgs. q.i.d. The patient's course in the hospital was otherwise uneventful except for
occasional pain in the left eye. At the time of discharge on 5-3-55 the vision with
correction for the right eye was 20/20 and the left eye vision was 20/70. The fundus
picture was essentially the same as on admission.
After her discharge, the patient was maintained on prednisolone 5 mgs. q.i.d.
and hedulin 100 mgs. daily on an OPD basis by her ophthalmologist at home for
approximately 2 weeks. She was kind enough to return 4 weeks later on June 1, 1955
to permit us to observe her progress. Corrected vision in left eye had improved to 20/30,
tension was 17 mms. Schiotz and the ophthalmoscopic appearance of the fundus was
essentially unchanged except that a few of the hemorrhages had apparently disappeared.
Perhaps the solution to the problem of evaluating anticoagulants in the management
of venous occlusion lies in the recent suggestion of Maumenee'. He proposed that
selected hospitals all over the United States be designated as treatment centers. On
"odd days" of the year patients admitted with the diagnosis of venous occlusion would
be placed on anticoagulants; on "even days" patients admitted could act as a control
group and receive none. By standardizing the criteria for diagnosis of occlusion and the
schema for the type and dosage of anticoagulants, a logical evaluation could be arrived
at.
After evaluating anticoagulants, perhaps one step further, the value of steroids in
the management of venous occlusion could be assessed.
Summary: A 36 year old white female was seen in the H . F. H . chnic with the
diagnosis of central retinal vein occlusion, left eye, 4 days after the onset of symptoms.
The patient was maintained on hedulin anticoagulant therapy for approximately 8
weeks with only irregular control of the prothrombin time. The irregularity was presumed to be in part due to the concomitant steroid therapy administered. Visual acuity
on initial examination was L E : with correction 20/30; throughout the hospital stay
the visual acuity tended to diminish but showed marked improvement when ACTH
was added to the therapeutic regimen. On removal of the ACTH the vision again
decreased. Visual acuity at final examination was L E 20/30 and the intraocular tension
was normal.
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